Bristol-Myers, Novartis Settle With Teva Over HIV Drug IP
Pharmaceutical giants Bristol-Myers Squibb Co. and Novartis Corp. settled a patent dispute with Teva Pharmaceuticals USA Inc. on Monday, ending a consolidated suit over Teva's attempt to introduce a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article